{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 622"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to\n\t\t  reauthorize user fee programs relating to new animal drugs and generic new\n\t\t  animal drugs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "#text": "March 20, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": ", from the\n\t\t\t ", "#text": "Mr. Harkin", "@name-id": "S172"}, "committee-name": {"#tail": ", reported the following original bill; which was\n\t\t\t read twice and placed on the calendar", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor,\n\t\t\t and Pensions"}}, "#text": "\n\t\t\t"}, "calendar": {"#tail": "\n\t\t", "#text": "Calendar No. 31"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Placed-on-Calendar-Senate", "endorsement": {"action-date": {"#tail": "\n\t\t", "#text": "March 20, 2013"}, "#tail": "\n", "action-desc": {"#tail": "\n\t", "#text": "Read twice and placed on the calendar"}, "#text": "\n\t\t"}, "@public-private": "public", "legis-body": {"#tail": "\n\t", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Animal Drug and Animal Generic\n\t\t\t Drug User Fee Reauthorization Act of 2013", "@value": "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Table of\n\t\t\t contents; references in Act"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The table of contents of this Act is as follows:"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Table of\n\t\t\t contents"}, "toc": {"#tail": "\n\t\t\t", "#text": "\n\t\t\t\t\t", "toc-entry": [{"@idref": "S1", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 1. Short\n\t\t\t\ttitle.", "@level": "section"}, {"@idref": "id6DDE233C8DD34BA49B288F3202F70B43", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 2. Table of contents; references in Act.", "@level": "section"}, {"@idref": "idCAB9CAD96B1741ABBCE4EB6FD7B2A456", "#tail": "\n\t\t\t\t\t", "#text": "TITLE I\u2014Fees relating to animal drugs", "@level": "title"}, {"@idref": "idF24B38947FC6403FAF022C0E445C8BB9", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 101. Short title; finding.", "@level": "section"}, {"@idref": "id18C46899033642ECAD36671387E81948", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 102. Definitions.", "@level": "section"}, {"@idref": "idE57FA6A8996142F597DE8AD3F7810778", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 103. Authority to assess and use animal drug\n\t\t\t\tfees.", "@level": "section"}, {"@idref": "idF95379A251544E6E81CF9BBCFDFA1C6E", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 104. Reauthorization; reporting requirements.", "@level": "section"}, {"@idref": "idba28b0f6449e4cf594c392846a403b7d", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 105. Savings clause.", "@level": "section"}, {"@idref": "idc9d1267aec5c4c19b7d4aa9c166e8eee", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 106. Effective date.", "@level": "section"}, {"@idref": "id0b82b2aad4a449f1a2d259581c5c328c", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 107. Sunset dates.", "@level": "section"}, {"@idref": "id887345CBA94A46EFAF59D050D74EF0E8", "#tail": "\n\t\t\t\t\t", "#text": "TITLE II\u2014Fees relating to generic animal drugs", "@level": "title"}, {"@idref": "id7BD7ADAD8E32489AACA44A75A67EB6D3", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 201. Short title; finding.", "@level": "section"}, {"@idref": "id105B4517DF0E45CC895D417541929E33", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 202. Authority to assess and use generic new animal drug\n\t\t\t\tfees.", "@level": "section"}, {"@idref": "id86BF1F833AFE43B28EDEE90F35A3DA96", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 203. Reauthorization; reporting requirements.", "@level": "section"}, {"@idref": "idE3F39FD53D1C45CCAF4D42AE9FAB3054", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 204. Savings clause.", "@level": "section"}, {"@idref": "id0093861360504679B096AF5D36435FAA", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 205. Effective date.", "@level": "section"}, {"@idref": "id6738992BAF6E4409B631A215FF4D8E5C", "#tail": "\n\t\t\t\t", "#text": "Sec. 206. Sunset dates.", "@level": "section"}]}, "#text": "\n        ", "@id": "id6563FD38C07040FEB98F43E38C40CD71"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Except as otherwise specified, amendments made by this Act to\n\t\t\t a section or other provision of law are amendments to such section or other\n\t\t\t provision of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et\n\t\t\t seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "References in\n\t\t\t Act"}, "#text": "\n        ", "@id": "idE29AD33021E4498E9F8AC1985ECF307F"}], "#text": "\n      ", "@id": "id6DDE233C8DD34BA49B288F3202F70B43"}], "#text": "\n\t\t", "title": [{"#tail": "\n    ", "section": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "101."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title;\n\t\t\t finding"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Animal Drug User Fee\n\t\t\t Amendments of 2013", "@value": "Animal Drug User Fee Amendments of 2013", "@proposed": "true"}, "#text": "\n              "}, "#text": "This title may be cited as the "}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short\n\t\t\t title"}, "#text": "\n          ", "@id": "id4D67D4B50BC5474399DBCD21987163B9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t finds that the fees authorized by the amendments made in this title will be\n\t\t\t dedicated toward expediting the animal drug development process and the review\n\t\t\t of new and supplemental animal drug applications and investigational animal\n\t\t\t drug submissions as set forth in the goals identified, for purposes of ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", in\n\t\t\t the letters from the ", "@entity-type": "act", "#text": "part 4\n\t\t\t of subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, {"#tail": " to the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the\n\t\t\t ", "@entity-type": "committee", "#text": "Chairman of\n\t\t\t the Committee on Energy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on Health, Education, Labor, and Pensions of the\n\t\t\t Senate", "@entity-id": "SSHR00"}], "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding"}, "#text": "\n          ", "@id": "idCCB5BB80E2324FCCBA82464242AA3C39"}], "#text": "\n        ", "@id": "idF24B38947FC6403FAF022C0E445C8BB9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 739 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:739"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201311", "@value": "usc/21/379j\u201311"}, "@parsable-cite": "usc/21/379j-11", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "102."}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For purposes of this part:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n            ", "#text": "739."}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ". Such term does not include\n\t\t\t\teither a new animal drug application submitted under ", "@entity-type": "act", "#text": "section 512(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:1"}, {"#tail": " or a\n\t\t\t\tsupplemental animal drug application.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}], "term": {"#tail": " means an application for approval of any\n\t\t\t\tnew animal drug submitted under ", "#text": "animal drug application"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "id2baecaa2201646fd847452d9d7af16b4", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "supplemental animal drug application"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "id75dc24faa3c34c498fbfd7528f195f29", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve a change in an animal drug application which has been\n\t\t\t\tapproved; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "a request to the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id8d119fd21c4648d1a326ef814ae2b4b4", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to approve a change to an application approved under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for which data with respect to safety or effectiveness are\n\t\t\t\trequired.", "@entity-type": "act", "#text": "section\n\t\t\t\t512(c)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:c/p:2"}], "#text": "a request to the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id51e3012b17c1410a992ed6c288462421", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means each specific strength or potency of a\n\t\t\t\tparticular active ingredient or ingredients in final dosage form marketed by a\n\t\t\t\tparticular manufacturer or distributor, which is uniquely identified by the\n\t\t\t\tlabeler code and product code portions of the national drug code, and for which\n\t\t\t\tan animal drug application or a supplemental animal drug application has been\n\t\t\t\tapproved.", "#text": "animal drug product"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "id6a97e76f119640d7b7489daab6a5cb06", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a foreign or domestic place of\n\t\t\t\tbusiness which is at one general physical location consisting of one or more\n\t\t\t\tbuildings all of which are within 5 miles of each other, at which one or more\n\t\t\t\tanimal drug products are manufactured in final dosage form.", "#text": "animal drug establishment"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "id45066d48e5bb4af196d4277a5d52bba1", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "investigational animal drug submission"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "#text": "\n              ", "@id": "ide9601ceef80e4db78d44d5541181cf2b", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a new animal\n\t\t\t\tdrug intended to be the subject of an animal drug application or a supplemental\n\t\t\t\tanimal drug application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a\n\t\t\t\tclaim for an investigational exemption under "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id2edccab7936b46849d1ecbf6ec00a0d1", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of an animal drug application or supplemental animal drug\n\t\t\t\tapplication in the event of their filing.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id2752196ae8cb42f28d7d3fb12d4b4533", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " , or a person who has\n\t\t\t\tsubmitted an investigational animal drug submission that has not been\n\t\t\t\tterminated or otherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means either an applicant named in an animal\n\t\t\t\tdrug application that has not been withdrawn by the applicant and for which\n\t\t\t\tapproval has not been withdrawn by the ", "#text": "animal drug sponsor"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "@id": "idab5aa508c9ec4de8ac04cf107a60fd1b", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means, with respect to an animal drug product, a\n\t\t\t\tfinished dosage form which is approved for administration to an animal without\n\t\t\t\tsubstantial further manufacturing. Such term includes animal drug products\n\t\t\t\tintended for mixing in animal feeds.", "#text": "final dosage form"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "@id": "id59ce977dfbc243cab1f36852f9980932", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to the review of animal drug\n\t\t\t\tapplications, supplemental animal drug applications, and investigational animal\n\t\t\t\tdrug submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the\n\t\t\t\tfollowing activities of the ", "#text": "process for the review of animal drug applications"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(8)"}, "#text": "\n              ", "@id": "id8d7966ae48ef4a6fb99cb5bdb30638fd", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The activities\n\t\t\t\tnecessary for the review of animal drug applications, supplemental animal drug\n\t\t\t\tapplications, and investigational animal drug submissions."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id57760b3930c54f8b9873957f96fb72cb", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The issuance of\n\t\t\t\taction letters which approve animal drug applications or supplemental animal\n\t\t\t\tdrug applications or which set forth in detail the specific deficiencies in\n\t\t\t\tanimal drug applications, supplemental animal drug applications, or\n\t\t\t\tinvestigational animal drug submissions and, where appropriate, the actions\n\t\t\t\tnecessary to place such applications, supplements or submissions in condition\n\t\t\t\tfor approval."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id0e6dbab31cf54fd2a5ed64fd3059f60b", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s review of pending animal drug applications, supplemental animal\n\t\t\t\tdrug applications, and investigational animal drug submissions.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The inspection of\n\t\t\t\tanimal drug establishments and other facilities undertaken as part of the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "ida5ed9b515c064d799b9b1dd5bd635681", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Monitoring of\n\t\t\t\tresearch conducted in connection with the review of animal drug applications,\n\t\t\t\tsupplemental animal drug applications, and investigational animal drug\n\t\t\t\tsubmissions."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id4660e2af831f46c6b5219d1b9b5088a3", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The development\n\t\t\t\tof regulations and policy related to the review of animal drug applications,\n\t\t\t\tsupplemental animal drug applications, and investigational animal drug\n\t\t\t\tsubmissions."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id16c5e7d415c240c39e1a7764e7c8aa43", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Development of\n\t\t\t\tstandards for products subject to review."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "idbca0bdd8d87d4c42987b6660266a124a", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Meetings between\n\t\t\t\tthe agency and the animal drug sponsor."}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "idd31eb8de324c4ed98b7d171b426aa0d6", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Review of\n\t\t\t\tadvertising and labeling prior to approval of an animal drug application or\n\t\t\t\tsupplemental animal drug application, but not after such application has been\n\t\t\t\tapproved."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "id9ec33da95791400882f4a37b4d293a0d", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the expenses in connection with the process for\n\t\t\t\tthe review of animal drug applications for\u2014", "#text": "costs of resources allocated for the process for the review of animal\n\t\t\t\tdrug applications"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(9)"}, "#text": "\n              ", "@id": "id280ae9c17847498cb26aebb44e12376e", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", contractors of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", advisory committees consulted with respect to the review of\n\t\t\t\tspecific animal drug applications, supplemental animal drug applications, or\n\t\t\t\tinvestigational animal drug submissions, and costs related to such officers,\n\t\t\t\temployees, committees, and contractors, including costs for travel, education,\n\t\t\t\tand recruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "officers and\n\t\t\t\temployees of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id4a075b710b6a4c508c6b1e88e547b378", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "management of\n\t\t\t\tinformation and the acquisition, maintenance, and repair of computer\n\t\t\t\tresources;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idb8bac221e506493fa513ba7b1b6488cc", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "leasing,\n\t\t\t\tmaintenance, renovation, and repair of facilities and acquisition, maintenance,\n\t\t\t\tand repair of fixtures, furniture, scientific equipment, and other necessary\n\t\t\t\tmaterials and supplies; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id0f945ec9caf748b3a1398c0ece5557e3", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and accounting for resources allocated for the review of\n\t\t\t\tanimal drug applications, supplemental animal drug applications, and\n\t\t\t\tinvestigational animal drug submissions.", "@entity-type": "act", "#text": "section 740", "@value": "Federal Food, Drug, and Cosmetic Act/s:740", "@proposed": "true"}, "#text": "collecting fees\n\t\t\t\tunder "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id33d0d930d7814ff1ab1fa64b560de746", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with the base or comparator month being\n\t\t\t\tOctober 2002.", "@entity-type": "act", "#text": "section 735(8)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:8"}, "term": {"#tail": " applicable to a fiscal year refers to the\n\t\t\t\tformula set forth in ", "#text": "adjustment factor"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(10)"}, "@id": "idda64e305fd5e4f5ba8c1921029ec65db", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " includes an affiliate thereof.", "#text": "person"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(11)"}, "@id": "idd530b8631d82409d9e199b02bf4b90b9", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " refers to the definition set forth in ", "#text": "affiliate"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(12)"}, "@id": "ida520e53d480c419d99108ffc83029fe8", "#text": "\n              "}], "#text": "\n            ", "@id": "id2cfb2137b4f849b28383ff7535ad2157"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id2B676713CF5A43E7A28E98883B5193AF"}, "#text": "\n        ", "@id": "id18C46899033642ECAD36671387E81948"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201312", "@value": "usc/21/379j\u201312"}, "@parsable-cite": "usc/21/379j-12", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "103."}, "header": {"#tail": "\n        ", "#text": "Authority to\n\t\t\t assess and use animal drug fees"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to\n\t\t\t\tassess and use animal drug fees"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall assess\n\t\t\t\tand collect fees in accordance with this section as follows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning in fiscal year 2004, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for an\n\t\t\t\tanimal drug application, except an animal drug application subject to the\n\t\t\t\tcriteria set forth in ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}], "#text": "A fee established in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idf3be932ff6c44f0eb559e8781c278625", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in an amount that is equal to 50 percent of the\n\t\t\t\tamount of the fee under ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", for\u2014", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A/cl:i", "@proposed": "true"}], "#text": "A fee\n\t\t\t\testablished in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a supplemental\n\t\t\t\tanimal drug application for which safety or effectiveness data are required;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id71eba9cd8cc9432bb086eae9b19271f1", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, "#text": "an animal drug application subject to the\n\t\t\t\tcriteria set forth in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "iddaa6e8cc556745eba9d35e6e6cfdf566", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id0ea29b3247bb47aebd6f6599a5adb1f7"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person that submits, on or after September 1, 2003,\n\t\t\t\tan animal drug application or a supplemental animal drug application shall be\n\t\t\t\tsubject to a fee as follows:"}, "#text": "\n                  ", "@id": "id96eff9f07a5842a4a4b1a8d0e987e7f7"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be due upon submission of the animal\n\t\t\t\tdrug application or supplemental animal drug application.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tfee required by "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment"}, "#text": "\n                  ", "@id": "idad0ccb7a9ce2485e856a3962aa83a00b"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "If an animal drug\n\t\t\t\tapplication or a supplemental animal drug application was submitted by a person\n\t\t\t\tthat paid the fee for such application or supplement, was accepted for filing,\n\t\t\t\tand was not approved or was withdrawn (without a waiver or refund), the\n\t\t\t\tsubmission of an animal drug application or a supplemental animal drug\n\t\t\t\tapplication for the same product by the same person (or the person\u2019s licensee,\n\t\t\t\tassignee, or successor) shall not be subject to a fee under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Exception for\n\t\t\t\tpreviously filed application or supplement"}, "#text": "\n                  ", "@id": "id00381df24dbb4c6fa9672051607e83ff"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any animal drug application\n\t\t\t\tor supplemental animal drug application which is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee\n\t\t\t\tif application refused for filing"}, "#text": "\n                  ", "@id": "id1fb0e71de8754f73b85f71fbdeec1d3a"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or portion of the fee\n\t\t\t\tpaid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was performed on the\n\t\t\t\tapplication or supplement after the application or supplement was filed. The\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " shall have the sole discretion to refund the fee under this\n\t\t\t\tparagraph. A determination by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this\n\t\t\t\tparagraph shall not be reviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an animal drug application or a\n\t\t\t\tsupplemental animal drug application is withdrawn after the application or\n\t\t\t\tsupplement was filed, the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee\n\t\t\t\tif application withdrawn"}, "#text": "\n                  ", "@id": "ida24a0748809b462995e81936d8d6a70c"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug\n\t\t\t\tapplication and supplement fee"}, "#text": "\n                ", "@id": "id856c6a5f331349858672440b4b1afaef"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall\n\t\t\t\tpay for each such animal drug product the annual fee established in "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as\n\t\t\t\tthe applicant in an animal drug application or supplemental animal drug\n\t\t\t\tapplication for an animal drug product which has been submitted for listing\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idBC3298020FB0493AA055F3DCBFD9368F", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application\n\t\t\t\tor supplemental animal drug application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2003, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id05148E5A0284418DA64B1C1692C81E56", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "ida938326684b7416ab2de970e84282893"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first\n\t\t\t\tbusiness day after the date of enactment of an appropriations Act providing for\n\t\t\t\tthe collection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id2a6ea392d4da47048129573d63242b2b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of\n\t\t\t\teach year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idb2ec0ea5d79140838a1d2f511c1e3dc7", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee\n\t\t\t\tdue date"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is\n\t\t\t\tsubmitted for relisting under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the animal drug product has been\n\t\t\t\twithdrawn from listing and relisted. After such fee is paid for that fiscal\n\t\t\t\tyear, such fee shall be due each subsequent fiscal year that the product\n\t\t\t\tremains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which\n\t\t\t\tthe animal drug product is first submitted for listing under "}, "#text": "\n                  ", "@id": "id286d4e36fdf44cd9bc435819a7fbd697"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such\n\t\t\t\tfee shall be paid only once for each animal drug product for a fiscal year in\n\t\t\t\twhich the fee is payable."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "id2c4425400aea4a6b88a4e752b3c37385"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug\n\t\t\t\tproduct fee"}, "#text": "\n                ", "@id": "idd244aeb1ac2344d6963dbdab2111e2ec"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for\n\t\t\t\teach animal drug establishment listed in its approved animal drug application\n\t\t\t\tas an establishment that manufactures the animal drug product named in the\n\t\t\t\tapplication.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall\n\t\t\t\tbe assessed an annual establishment fee as established in "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who owns or\n\t\t\t\toperates, directly or through an affiliate, an animal drug\n\t\t\t\testablishment;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id4acd4cf9864a448a847fa0d313f4f3a3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as\n\t\t\t\tthe applicant in an animal drug application or supplemental animal drug\n\t\t\t\tapplication for an animal drug product which has been submitted for listing\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id642d0b026cdc4f2bbe966b32014f852e", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application\n\t\t\t\tor supplemental animal drug application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2003, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id9c7fb6e0216b4ece94ac63dfe6413f60", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "id010c49a9657a4137bd22196c97c59427"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first\n\t\t\t\tbusiness day after the date of enactment of an appropriations Act providing for\n\t\t\t\tthe collection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id6c8e2638580f4fecab2326fb11e275e1", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of\n\t\t\t\teach year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id8288061bb7b24630b96cd9f96dad6f2e", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee\n\t\t\t\tdue date"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " unless the animal drug establishment listed\n\t\t\t\tin the application does not engage in the manufacture of the animal drug\n\t\t\t\tproduct during the fiscal year. The fee under this paragraph for a fiscal year\n\t\t\t\tshall be due upon the later of\u2014", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "The annual establishment fee shall be assessed in each\n\t\t\t\tfiscal year in which the animal drug product named in the application is\n\t\t\t\tassessed a fee under "}, "#text": "\n                  ", "@id": "id3f9baeb57de64faf8d8657f94716b49e"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3/sp:C/cl:ii", "@proposed": "true"}, "#text": "An establishment shall be assessed only one fee per\n\t\t\t\tfiscal year under this section, subject to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id85654F3F1AD54EE7BCE665138E7EBF7A"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tsuch establishment shall be assessed both the animal drug establishment fee and\n\t\t\t\tthe prescription drug establishment fee, as set forth in ", "@entity-type": "act", "#text": "section 735(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:3"}, {"#tail": ",\n\t\t\t\twithin a single fiscal year.", "@entity-type": "act", "#text": "section 736(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:736/ss:a/p:2"}], "#text": "If a single establishment manufactures both animal\n\t\t\t\tdrug products and prescription drug products, as defined in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain\n\t\t\t\tmanufacturers"}, "#text": "\n                    ", "@id": "id4C9A24E9FF104B879A9F8E585E05E10A"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Limitation"}, "#text": "\n                  ", "@id": "id1ca0cb6f97034855983c73b83030b397"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug\n\t\t\t\testablishment fee"}, "#text": "\n                ", "@id": "idec70ef13a7d74d6ba337a08e294490a4"}, {"#tail": "\n            ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall\n\t\t\t\tbe assessed an annual sponsor fee as established under "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the\n\t\t\t\tdefinition of an animal drug sponsor within a fiscal year; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id4713777554EA4736B68AE28C4A83A989", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who, after\n\t\t\t\tSeptember 1, 2003, had pending before the Secretary an animal drug application,\n\t\t\t\ta supplemental animal drug application, or an investigational animal drug\n\t\t\t\tsubmission,"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id75DDE84866DB44BCA26229F56E7666E2", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "idc86ef39ce2f34dd3a7ce643d12eba1a6"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first\n\t\t\t\tbusiness day after the date of enactment of an appropriations Act providing for\n\t\t\t\tthe collection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id7e4068f8a77841669b9f09685ef74e6e", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of\n\t\t\t\teach year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "iddb992fd0b12f410fb9360a188d36568c", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee\n\t\t\t\tdue date"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fee under this paragraph for a fiscal year shall be\n\t\t\t\tdue upon the later of\u2014"}, "#text": "\n                  ", "@id": "id9bbd59ab18014db9917df43009811793"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Each\n\t\t\t\tanimal drug sponsor shall pay only one such fee each fiscal year."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "idf247453a92744a588729e8746796c011"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug\n\t\t\t\tsponsor fee"}, "#text": "\n                ", "@id": "id5e99b2cdcba34a879d151c9d44a84bb1"}], "#text": "\n              ", "@id": "id2dc2344c349f4586842f585b9e903b2a"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee revenue\n\t\t\t\tamounts"}, "paragraph": [{"#tail": "\n              ", "@id": "idc6f6d9a0f4fb4101bf6de214b0d82488", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f", "@proposed": "true"}, {"#tail": "\u2014", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g", "@proposed": "true"}], "#text": "Subject to "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be established to generate a\n\t\t\t\ttotal revenue amount of $23,600,000; and", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for fiscal year\n\t\t\t\t2014, the fees required under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id6a536a7f69564371933dc08c908acabf", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\testablished to generate a total revenue amount of $21,600,000.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for each of\n\t\t\t\tfiscal years 2015 through 2018, the fees required under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idb13cfed06f6e4e7aa99336a2bf060685", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "idee0a35c16b3a4f43ad07525becf7368b", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Types of\n\t\t\t\tfees"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b/p:1", "@proposed": "true"}, "#text": "Of the total revenue amount determined for a fiscal year\n\t\t\t\tunder "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tapplications and supplements);", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1", "@proposed": "true"}, "#text": "20 percent shall\n\t\t\t\tbe derived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idcba4797710da4bcf9dac068921f3f593", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tproducts);", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "27 percent shall\n\t\t\t\tbe derived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "ide8c86e8cc8f744a99e582ad1290ed7eb", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\testablishments); and", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3", "@proposed": "true"}, "#text": "26 percent shall\n\t\t\t\tbe derived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id85513e950b0c458eb546e8af614947ef", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tsponsors).", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:4", "@proposed": "true"}, "#text": "27 percent shall\n\t\t\t\tbe derived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id3cd66be54caf46099e22401bebd73de5", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "idaf35bbefbdb747f09941f1977c0d1bdc"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee\n\t\t\t\tsetting; adjustments"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2003, for that fiscal year,\n\t\t\t\tanimal drug application fees, supplemental animal drug application fees, animal\n\t\t\t\tdrug sponsor fees, animal drug establishment fees, and animal drug product fees\n\t\t\t\tbased on the revenue amounts established under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the\n\t\t\t\tadjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee\n\t\t\t\tsetting"}, "#text": "\n                ", "@id": "id1be44308ec41422c91c09183f6d5a32f"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "The\n\t\t\t\tadjustment made each fiscal year under this paragraph shall be added on a\n\t\t\t\tcompounded basis to the sum of all adjustments made each fiscal year after\n\t\t\t\tfiscal year 2014 under this paragraph."}, "#tail": "\n              ", "@id": "idab2a98ea0a174a14b3c19e52ec354a1f", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Inflation\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": " by notice, published in the Federal Register, for a fiscal year, by\n\t\t\t\tan amount equal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the\n\t\t\t\trevenue amounts established in "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id11ecb2d82c084e5b85946436249a2b58", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 of the preceding 4 fiscal years\n\t\t\t\tfor which data are available, multiplied by the average proportion of personnel\n\t\t\t\tcompensation and benefits costs to total ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " costs for\n\t\t\t\tthe first 3 years of the preceding 4 fiscal years for which data are available;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id45520518539845659230174a4d7e3886", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " costs for the first 3 years of the preceding\n\t\t\t\t4 fiscal years for which data are available.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "the average\n\t\t\t\tannual percent change that occurred in the Consumer Price Index for urban\n\t\t\t\tconsumers (Washington-Baltimore, DC-MD-VA-WV; not seasonally adjusted; all\n\t\t\t\titems less food and energy; annual index) for the first 3 years of the\n\t\t\t\tpreceding 4 years for which data are available multiplied by the average\n\t\t\t\tproportion of all costs other than personnel compensation and benefits costs to\n\t\t\t\ttotal "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "ide1111c4d711a4bc0b60c7bdf4ef39252", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "ida926d9804abd48fa97bb5eafb148e7d3", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Workload\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " are adjusted for\n\t\t\t\tinflation in accordance with ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ", the revenue amounts shall be\n\t\t\t\tfurther adjusted for such fiscal year to reflect changes in the workload of the\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}, {"#tail": " for the process for the review of animal drug applications. With\n\t\t\t\trespect to such adjustment\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years,\n\t\t\t\tafter the revenue amounts established in "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change\n\t\t\t\tin the total number of animal drug applications, supplemental animal drug\n\t\t\t\tapplications for which data with respect to safety or effectiveness are\n\t\t\t\trequired, manufacturing supplemental animal drug applications, investigational\n\t\t\t\tanimal drug study submissions, and investigational animal drug protocol\n\t\t\t\tsubmissions submitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "such adjustment\n\t\t\t\tshall be determined by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id8cf934fc86e7475cb281bedfcfde33c6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall publish in the Federal Register the fees resulting from such adjustment\n\t\t\t\tand the supporting methodologies; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idA23B3BFEEFD947EDB19E5DF7AE6AB4DF", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as adjusted for inflation under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}], "#text": "under no\n\t\t\t\tcircumstances shall such adjustment result in fee revenues for a fiscal year\n\t\t\t\tthat are less than the fee revenues for that fiscal year established in\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id241d33caa9aa4458a1ffefc8dde96f73", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in\n\t\t\t\taddition to other adjustments under this subsection, further increase the fees\n\t\t\t\tunder this section, if such an adjustment is necessary, to provide for up to 3\n\t\t\t\tmonths of operating reserves of carryover user fees for the process for the\n\t\t\t\treview of animal drug applications for the first 3 months of fiscal year 2019.\n\t\t\t\tIf the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances for the process for\n\t\t\t\tthe review of animal drug applications in excess of 3 months of such operating\n\t\t\t\treserves, then this adjustment will not be made. If this adjustment is\n\t\t\t\tnecessary, then the rationale for the amount of the increase shall be contained\n\t\t\t\tin the annual notice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final year\n\t\t\t\tadjustment"}, "#text": "\n                ", "@id": "id22d236418f804be3a2a7dec79c87d001"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\ttotal amount of fees charged, as adjusted under this subsection, for a fiscal\n\t\t\t\tyear may not exceed the total costs for such fiscal year for the resources\n\t\t\t\tallocated for the process for the review of animal drug applications."}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Limit"}, "#text": "\n                ", "@id": "id41001dd940b1473fb08295986f21c6a6"}], "#text": "\n              ", "@id": "id1a1c4f8297ca4fa5adf7d7ad041d4c12"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee waiver or\n\t\t\t\treduction"}, "paragraph": [{"#tail": "\n              ", "@id": "idaca03700b2a3458da373e43ed7ee6165", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction of\n\t\t\t\tone or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " finds\n\t\t\t\tthat\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the assessment of\n\t\t\t\tthe fee would present a significant barrier to innovation because of limited\n\t\t\t\tresources available to such person or other circumstances;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id0605974517334d95abb436828ad5217f", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in conducting the process for the review of animal\n\t\t\t\tdrug applications for such person;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the fees to be\n\t\t\t\tpaid by such person will exceed the anticipated present and future costs\n\t\t\t\tincurred by the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id748e3a4b940b4602a7fed665a4d4d2f9", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the animal drug\n\t\t\t\tapplication or supplemental animal drug application is intended solely to\n\t\t\t\tprovide for use of the animal drug in\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a\n\t\t\t\tType B medicated feed (as defined in ", "external-xref": {"#tail": " of title 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulation)) intended for use in the\n\t\t\t\tmanufacture of Type C free-choice medicated feeds; or", "@parsable-cite": "usc/21/558", "#text": "section 558.3(b)(3)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "ide819f3de5b8445eebfd87cb6df3ffdfb", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a Type C\n\t\t\t\tfree-choice medicated feed (as defined in ", "external-xref": {"#tail": " of title 21, Code\n\t\t\t\tof Federal Regulations (or any successor regulation));", "@parsable-cite": "usc/21/558", "#text": "section 558.3(b)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "ida97a890bfb924c4f97282e53e50429be", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id0888a19d88004833bc3af69869fd5f22"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the animal drug\n\t\t\t\tapplication or supplemental animal drug application is intended solely to\n\t\t\t\tprovide for a minor use or minor species indication; or"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id54867149a9004d5fa36e326209f80ad0", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for review.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the sponsor\n\t\t\t\tinvolved is a small business submitting its first animal drug application to\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id27ee5fb886bf42fdb513d26ac1754466", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:B", "@proposed": "true"}, {"#tail": "\n\t\t\t\tmay use standard costs.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In making the finding in "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Use of standard\n\t\t\t\tcosts"}, "#text": "\n                ", "@id": "idf1216e118c0a48c2941625019319b283"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, "term": {"#tail": " means an entity that has\n\t\t\t\tfewer than 500 employees, including employees of affiliates.", "#text": "small business"}, "#text": "In\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Definition"}, "#text": "\n                  ", "@id": "id63490f3311f24674a2a20d163fa01089"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall waive under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tthe application fee for the first animal drug application that a small business\n\t\t\t\tor its affiliate submits to the ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " for review. After a small business or\n\t\t\t\tits affiliate is granted such a waiver, the small business or its affiliate\n\t\t\t\tshall pay application fees for all subsequent animal drug applications and\n\t\t\t\tsupplemental animal drug applications for which safety or effectiveness data\n\t\t\t\tare required in the same manner as an entity that does not qualify as a small\n\t\t\t\tbusiness.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Waiver of\n\t\t\t\tapplication fee"}, "#text": "\n                  ", "@id": "id8389047c675f4977af7588406623de9b"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require any person who applies for a waiver under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to certify their qualification for the waiver. The ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " shall\n\t\t\t\tperiodically publish in the Federal Register a list of persons making such\n\t\t\t\tcertifications.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Certification"}, "#text": "\n                  ", "@id": "ide87ea137ffb94c83ba6358425b8ae68b"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Rules for small\n\t\t\t\tbusinesses"}, "#text": "\n                ", "@id": "idac78667703e048a2a2b309c08878a132"}], "#text": "\n              ", "@id": "id5f5654bf3e724bb5ad446f03903c5dad"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered incomplete and shall not be accepted for filing by the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person have been paid. An investigational\n\t\t\t\tanimal drug submission under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that is submitted by a person\n\t\t\t\tsubject to fees under ", "@entity-type": "act", "#text": "section 739(5)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:739/p:5/sp:B", "@proposed": "true"}, {"#tail": " shall be considered incomplete and shall\n\t\t\t\tnot be accepted for review by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person\n\t\t\t\thave been paid. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may discontinue review of any animal drug\n\t\t\t\tapplication, supplemental animal drug application or investigational animal\n\t\t\t\tdrug submission from a person if such person has not submitted for payment all\n\t\t\t\tfees owed under this section by 30 days after the date upon which they are\n\t\t\t\tdue.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An animal drug application or supplemental\n\t\t\t\tanimal drug application submitted by a person subject to fees under "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of\n\t\t\t\tfailure To pay fees"}, "#text": "\n              ", "@id": "ide7cd2c8d294d4fc3ae7c308c5a04b6f2"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2003 unless appropriations for salaries and expenses of the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the ", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, {"#tail": " for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "Fees\n\t\t\t\tmay not be assessed under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "#text": "\n                ", "@id": "id8097173620504c51b2377b93e98f8166"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a fiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " and\n\t\t\t\tif at a later date in such fiscal year the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such fees, without any modification in the\n\t\t\t\trate, for animal drug applications, supplemental animal drug applications,\n\t\t\t\tinvestigational animal drug submissions, animal drug sponsors, animal drug\n\t\t\t\testablishments and animal drug products at any time in such fiscal year\n\t\t\t\tnotwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " relating to the date fees are\n\t\t\t\tto be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}], "#text": "If the "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority"}, "#text": "\n                ", "@id": "ide7984a1f0bf44d048c6f6fc03396fa82"}], "#text": "\n              ", "@id": "id65edffaa16784560a40ead49845e81e5"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of animal drug applications.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id69eefe8b0407495781fe5652401c79d4"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be\n\t\t\t\tcollected and available in each fiscal year in an amount not to exceed the\n\t\t\t\tamount specified in appropriation Acts, or otherwise made available for\n\t\t\t\tobligation for such fiscal year, and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id06bada831ef44b2b83d2b209e2b20282", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be engaged in such process) over\n\t\t\t\tsuch costs, excluding costs paid from fees collected under this section, for\n\t\t\t\tfiscal year 2003 multiplied by the adjustment factor.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "shall be\n\t\t\t\tavailable to defray increases in the costs of the resources allocated for the\n\t\t\t\tprocess for the review of animal drug applications (including increases in such\n\t\t\t\tcosts for an additional number of full-time equivalent positions in the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id46588b6b48e84a3f83c15e128c4fd3b2", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014"}, "#text": "\n                  ", "@id": "id1e7f16bd4e9244d19b3f9d9a1b05c393"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than\n\t\t\t\t3 percent below the level specified in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id403d638ecdd940a8b4b5df219a49f2c2", "#text": "\n                    "}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the\n\t\t\t\tfiscal year following the subsequent fiscal year are decreased by the amount in\n\t\t\t\texcess of 3 percent by which such costs fell below the level specified in\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id843D35BAAB274BAFB62E986A7096C7C2", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more than 5 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "idB5FA6A04D5DF454B997DB044F9DFCE62"}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id5d49f7d3dd7949dabc7af64aa5601d38", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Compliance"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of animal drug applications\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "#text": "\n                  ", "@id": "id392449b0361a4c37b7b53aad1ef92fcb"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior year\n\t\t\t\tappropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this section for\n\t\t\t\ta fiscal year, prior to the due date for such fees, may be accepted by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for\n\t\t\t\tearly payments"}, "#text": "\n                  ", "@id": "id31dff28713af4d34bad74c8d4bee74b4"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and\n\t\t\t\tappropriation acts"}, "#text": "\n                ", "@id": "id9f693160d00841d9812c3b60ddd7ac5f"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "\n                      \n                    .", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for the\n\t\t\t\tfiscal year, as adjusted or otherwise affected under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": "\n                    ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4", "@proposed": "true"}], "@amount": "indefinite", "#text": "an amount\n\t\t\t\tequal to the total revenue amount determined under ", "@year": "2014, 2015, 2016, 2017, 2018"}, "@entity-type": "auth-auth-approp", "#text": "\n                    For each of the fiscal years 2014 through 2018,\n\t\t\t\tthere is authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}property": {"#tail": " ", "#text": "for fees under this section", "@name": "purpose"}}}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorization\n\t\t\t\tof appropriations"}, "#text": "\n                ", "@id": "id9edc07c1ec99401386901a6f38345481"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "),\n\t\t\t\texceeds the cumulative amount appropriated pursuant to ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:B", "@proposed": "true"}, {"#tail": " for the\n\t\t\t\tfiscal years 2014 through 2017, the excess amount shall be credited to the\n\t\t\t\tappropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from the amount of fees that would\n\t\t\t\totherwise be authorized to be collected under this section pursuant to\n\t\t\t\tappropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:1", "@proposed": "true"}], "#text": "If the sum of the cumulative amount of fees\n\t\t\t\tcollected under this section for fiscal years 2014 through 2016 and the amount\n\t\t\t\tof fees estimated to be collected under this section for fiscal year 2017\n\t\t\t\t(including any increased fee collections attributable to "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Offset of\n\t\t\t\tovercollections"}, "#text": "\n                  ", "@id": "id184e5d32ed594ca0bf3ffd409d100a1c"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2016, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2014 falls below the amount of fees authorized for fiscal year 2014\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2016"}, "#text": "\n                    ", "@id": "id104c67d7fb734180b2c3e8a8b1a865b4"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2017, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2015 falls below the amount of fees authorized for fiscal year 2015\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2017"}, "#text": "\n                    ", "@id": "id734261ab2af44cfe94750df06bcd059a"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), shall be increased by the cumulative\n\t\t\t\tamount, if any, by which the amount collected under this section and\n\t\t\t\tappropriated for fiscal years 2016 and 2017 (including estimated collections\n\t\t\t\tfor fiscal year 2017) falls below the cumulative amount of fees authorized\n\t\t\t\tunder ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:A", "@proposed": "true"}, {"#tail": " for fiscal years 2016 and 2017.", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}], "#text": "For fiscal year 2018, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section (including any reduction in the\n\t\t\t\tauthorized amount under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2018"}, "#text": "\n                    ", "@id": "idcce94146ddcd49a68e7c0fff8fff7738"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Recovery of\n\t\t\t\tcollection shortfalls"}, "#text": "\n                  ", "@id": "id59f70c4eda2b48a990d9c7b9ac351e11"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Offset of\n\t\t\t\tovercollections; recovery of collection shortfalls"}, "#text": "\n                ", "@id": "idccfd5c44eb3448a68c4d6e6b4c9dd806"}], "#text": "\n              ", "@id": "id26b0ce484bc3479abb5a8698156becd0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive\n\t\t\t\tpayment of a fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n              ", "@id": "idc76efd22b8394a63903cc6e58714edf1"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund\n\t\t\t\tof any fee collected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit\n\t\t\t\tto the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not\n\t\t\t\tlater than 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for\n\t\t\t\tconsideration for a waiver or reduction under "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written\n\t\t\t\trequests for waivers, reductions, and refunds"}, "#text": "\n              ", "@id": "idda35a235af3e4f8f9c8d98427c724d62"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tanimal drug applications, be reduced to offset the number of officers,\n\t\t\t\temployees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the "}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction"}, "#text": "\n              ", "@id": "id711bcda79b1640eda8809e41b0caa566"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Abbreviated new\n\t\t\t\tanimal drug applications"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to the extent\n\t\t\t\tpracticable, segregate the review of abbreviated new animal drug applications\n\t\t\t\tfrom the process for the review of animal drug applications; and"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "id33baecf53cf54a36b38df809eb9926cb", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "adopt other\n\t\t\t\tadministrative procedures to ensure that review times of abbreviated new animal\n\t\t\t\tdrug applications do not increase from their current level due to activities\n\t\t\t\tunder the user fee\n\t\t\t\tprogram."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "idfcf2953d5595412b81d55a821bdc4cf6", "#text": "\n                "}], "#text": "\n              ", "@id": "id16bb5dd7abb14d298f632d69081702f3"}], "#text": "\n            ", "@id": "id20bd7243cd6d4ec0bde67d3531977f61"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idE6F90BE0E0A74214B31A51B5B1004BEC"}, "#text": "\n        ", "@id": "idE57FA6A8996142F597DE8AD3F7810778"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740A of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201313", "@value": "usc/21/379j\u201313"}, "@parsable-cite": "usc/21/379j-13", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "104."}, "header": {"#tail": "\n        ", "#text": "Reauthorization;\n\t\t\t reporting requirements"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization;\n\t\t\t\treporting requirements"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report concerning the\n\t\t\t\tprogress of the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " in achieving the goals identified\n\t\t\t\tin the letters described in ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " toward expediting the animal drug development process and\n\t\t\t\tthe review of the new and supplemental animal drug applications and\n\t\t\t\tinvestigational animal drug submissions during such fiscal year, the future\n\t\t\t\tplans of the ", "@entity-type": "act", "#text": "section 101(b) of the Animal Drug User Fee\n\t\t\t\tAmendments of 2013", "@value": "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013/t:I/s:101/ss:b", "@proposed": "true"}, {"#tail": " for meeting the goals, the review\n\t\t\t\ttimes for abbreviated new animal drug applications, and the administrative\n\t\t\t\tprocedures adopted by the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " to ensure that review\n\t\t\t\ttimes for abbreviated new animal drug applications are not increased from their\n\t\t\t\tcurrent level due to activities under the user fee program.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance\n\t\t\t\treport"}, "#text": "\n              ", "@id": "ide710374a1b3649a282c6a20d66db3469"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report on the implementation of the\n\t\t\t\tauthority for such fees during such fiscal year and the use, by the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", of the fees collected during such fiscal year for which\n\t\t\t\tthe report is made.", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later than 120 days\n\t\t\t\tafter the end of each fiscal year during which fees are collected under this\n\t\t\t\tpart, the "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal\n\t\t\t\treport"}, "#text": "\n              ", "@id": "id036e8e685fd2433a9a150752fc6853c9"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports required under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet Web site of the\n\t\t\t\t", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n              ", "@id": "id70c74929fa794ceda549be2e4bcdb860"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization"}, "paragraph": [{"#tail": "\n              ", "@id": "id57095eef82914448879892c2b5cfe99c", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the\n\t\t\t\tgoals, and plans for meeting the goals, for the process for the review of\n\t\t\t\tanimal drug applications for the first 5 fiscal years after fiscal year 2018,\n\t\t\t\tand for the reauthorization of this part for such fiscal years, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": "\n\t\t\t\tshall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "ide111af8ca37e4693b84ca1626c83cd47", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id448d41d83bf441b3a1391bff9bad9137", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and\n\t\t\t\tacademic experts;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id07b24380644a4aabae82feedc049e120", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary\n\t\t\t\tprofessionals;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id9008aebf19cc479e8b2fd3c7e20d0f68", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives\n\t\t\t\tof patient and consumer advocacy groups; and"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "idd5d4740bfc954e24b85d86514a3b9cf6", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated\n\t\t\t\tindustry."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "idef604a0ab22e4a57b6ea8698e136787b", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id89f90dbdd5e04ec2aa435447045e507b", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public\n\t\t\t\tinput"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the regulated industry\n\t\t\t\ton the reauthorization of this part, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register requesting public input on the reauthorization;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idd1d66eb433a645658f2b64fc5667fa96", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, "#text": "hold a public\n\t\t\t\tmeeting at which the public may present its views on the reauthorization,\n\t\t\t\tincluding specific suggestions for changes to the goals referred to in\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id269baaa080b84fef91902ca8d2aa46a3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof 30 days after the public meeting to obtain written comments from the public\n\t\t\t\tsuggesting changes to this part; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id7496a4dca3e8451f85d7842dd3216a64", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s Internet Web site.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "publish the\n\t\t\t\tcomments on the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id67d013b5e00b4c48a9e36b7df2599129", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall hold discussions\n\t\t\t\twith representatives of veterinary, patient, and consumer advocacy groups to\n\t\t\t\tcontinue discussions of their views on the reauthorization and their\n\t\t\t\tsuggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4 months during\n\t\t\t\tnegotiations with the regulated industry, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic\n\t\t\t\tconsultation"}, "#text": "\n                ", "@id": "id9230d0a90c734dc5a1058fe99e46cfa9"}, {"#tail": "\n              ", "@id": "id57f685acb120400697565bc2d0b43fbc", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review\n\t\t\t\tof recommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After negotiations with the regulated\n\t\t\t\tindustry, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the Congressional committees\n\t\t\t\tspecified in such paragraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1", "@proposed": "true"}, "#text": "present the\n\t\t\t\trecommendations developed under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idf9b35f1dc4d6427895456dc260e75775", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such\n\t\t\t\trecommendations in the Federal Register;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idcc769eebd7dc40a8bbe143ac09353cba", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a\n\t\t\t\tperiod of 30 days for the public to provide written comments on such\n\t\t\t\trecommendations;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "idac581df369e847d89cedc615ed466f56", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at\n\t\t\t\twhich the public may present its views on such recommendations; and"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id2cfd442b7abd45d9b39640e83aaaf812", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after\n\t\t\t\tconsideration of such public views and comments, revise such recommendations as\n\t\t\t\tnecessary."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id6f12127e7ba64095b14fef4d8d658e5a", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall transmit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the revised\n\t\t\t\trecommendations under ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " a summary of the views and comments\n\t\t\t\treceived under such paragraph, and any changes made to the recommendations in\n\t\t\t\tresponse to such views and comments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:4", "@proposed": "true"}], "#text": "Not later\n\t\t\t\tthan January 15, 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations"}, "#text": "\n                ", "@id": "idd01a91d0528f42da94f26ccb08545148"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1, 2, 3, 4, 5", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall make publicly\n\t\t\t\tavailable, on the Internet Web site of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t\tminutes of all negotiation meetings conducted under this subsection between the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " and the regulated industry.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Before presenting the recommendations developed\n\t\t\t\tunder "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n                  ", "@id": "id9cb0747cfca04ad1ab544a53081714dc"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive\n\t\t\t\tproposal made by any party to the negotiations as well as significant\n\t\t\t\tcontroversies or differences of opinion during the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tminutes described under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content"}, "#text": "\n                  ", "@id": "id815564b6c0a64e78b0bf983cb962efa2"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of\n\t\t\t\tnegotiation meetings"}, "#text": "\n                ", "@id": "ida076c7807f1d43238f245a5a5e6d8458"}], "#text": "\n              ", "@id": "idebefb335a8394bb6b022f739b5489539"}], "#text": "\n            ", "@id": "id169ab2424afb43bba1e9aa0871d919b9"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id42045B5453184AC8B1E58DE58F9C326B"}, "#text": "\n        ", "@id": "idF95379A251544E6E81CF9BBCFDFA1C6E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "this title", "@value": "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013/t:I", "@proposed": "true"}, {"#tail": " for filing with respect to assessing and collecting any fee\n\t\t\t required by such part for a fiscal year prior to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}], "#text": "Notwithstanding the\n\t\t\t amendments made by ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as in effect\n\t\t\t on the day before the date of the enactment of this title, shall continue to be\n\t\t\t in effect with respect to animal drug applications and supplemental animal drug\n\t\t\t applications (as defined in such part as of such day) that on or after October\n\t\t\t 1, 2008, but before October 1, 2013, were accepted by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part 4 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201311 et seq.", "@value": "usc/21/379j\u201311/etseq"}, "@parsable-cite": "usc/21/379j-11", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "105."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause"}, "#text": "\n        ", "@id": "idba28b0f6449e4cf594c392846a403b7d"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this Act, whichever is later, except that fees under ", "@entity-type": "act", "#text": "this title", "@value": "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013/t:I", "@proposed": "true"}, {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all animal drug applications and supplemental\n\t\t\t animal drug applications received on or after October 1, 2013, regardless of\n\t\t\t the date of the enactment of this Act.", "@entity-type": "act", "#text": "part 4 of subchapter C of\n\t\t\t chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}], "#text": "The amendments made by\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "106."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "idc9d1267aec5c4c19b7d4aa9c166e8eee"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "107."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset\n\t\t\t dates"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201312", "@value": "usc/21/379j\u201312"}, "@parsable-cite": "usc/21/379j-12", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization"}, "#text": "\n          ", "@id": "ida4a641c87d6f448487f5da62d52db76d"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740A of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201313", "@value": "usc/21/379j\u201313"}, "@parsable-cite": "usc/21/379j-13", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting\n\t\t\t requirements"}, "#text": "\n          ", "@id": "id4cf78229349d409dbfb2ecdbcbe4b405"}, {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset\n\t\t\t provision"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 108 of the Animal Drug User Fee Amendments of\n\t\t\t 2008", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, "@parsable-cite": "pl/110/316", "#text": "\n                  ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t general"}, "#text": "\n            ", "@id": "idF96D025B9B954D67B403EB31E8339400"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 108", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in section 1, by striking the item\n\t\t\t relating to ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Animal Drug User Fee Amendments of 2008", "@value": "Animal Drug User Fee Amendments of 2008"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public Law\n\t\t\t 110\u2013316", "@value": "public-law/110/316"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n            ", "@id": "id704437d4593445a1b663af92ade5d290"}], "#text": "\n          ", "@id": "id4a9f8594497e4531a4856d553c4bbacf"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Effective November 18, 2003, ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 5 of the\n\t\t\t Animal Drug User Fee Act of 2003", "@value": "Animal Drug User Fee Act of 2003/s:5"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "public-law", "#text": "Public Law 108\u2013130", "@value": "public-law/108/130"}, "@parsable-cite": "pl/108/130", "#text": "\n                ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n          ", "#text": "(d)"}, "header": {"#tail": "\n          ", "#text": "Technical\n\t\t\t clarification"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id9d1d603607f54f548b231acd56ef8fc7", "@commented": "no"}], "#text": "\n        ", "@id": "id0b82b2aad4a449f1a2d259581c5c328c"}], "enum": {"#tail": "\n      ", "#text": "I"}, "header": {"#tail": "\n\t\t\t", "#text": "Fees\n\t\t\t relating to animal drugs"}, "#text": "\n      ", "@id": "idCAB9CAD96B1741ABBCE4EB6FD7B2A456"}, {"#tail": "\n  ", "section": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "201."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title;\n\t\t\t finding"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Animal Generic Drug\n\t\t\t User Fee Amendments of 2013", "@value": "Animal Generic Drug User Fee Amendments of 2013", "@proposed": "true"}, "#text": "\n              "}, "#text": "This title may be cited as the "}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short\n\t\t\t title"}, "#text": "\n          ", "@id": "id5B7258CB595642B195BCA087E66A0A86"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Chairman of the Committee on Energy and\n\t\t\t Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the\n\t\t\t Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on\n\t\t\t Health, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "The\n\t\t\t fees authorized by this title will be dedicated toward expediting the generic\n\t\t\t new animal drug development process and the review of abbreviated applications\n\t\t\t for generic new animal drugs, supplemental abbreviated applications for generic\n\t\t\t new animal drugs, and investigational submissions for generic new animal drugs\n\t\t\t as set forth in the goals identified in the letters from the "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding"}, "#text": "\n          ", "@id": "id3676933E1331421F958CC0D6921A8692", "@commented": "no"}], "#text": "\n        ", "@id": "id7BD7ADAD8E32489AACA44A75A67EB6D3"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 741 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201321", "@value": "usc/21/379j\u201321"}, "@parsable-cite": "usc/21/379j-21", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "202."}, "header": {"#tail": "\n        ", "#text": "Authority to\n\t\t\t assess and use generic new animal drug fees"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "741."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to\n\t\t\t\tassess and use generic new animal drug fees"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall assess and collect fees in accordance with this section as\n\t\t\t\tfollows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning with respect to fiscal year 2009, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such an application.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "Each person that submits, on or after July 1, 2008, an\n\t\t\t\tabbreviated application for a generic new animal drug shall be subject to a fee\n\t\t\t\tas established in "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id64e19cdb78e846eb9618119a878bcb6e"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tfee required by subparagraph (A) shall be due upon submission of the\n\t\t\t\tabbreviated application."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment"}, "#text": "\n                  ", "@id": "iddf1c179e7f89415cb864455241acc50c"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "If an abbreviated application was submitted by\n\t\t\t\ta person that paid the fee for such application, was accepted for filing, and\n\t\t\t\twas not approved or was withdrawn (without a waiver or refund), the submission\n\t\t\t\tof an abbreviated application for the same product by the same person (or the\n\t\t\t\tperson\u2019s licensee, assignee, or successor) shall not be subject to a fee under\n\t\t\t\tsubparagraph (A)."}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Previously\n\t\t\t\tfiled application"}, "#text": "\n                    ", "@id": "idf1a2fedb5ba147c694c99c050050e03d"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tand submitted on or after October 1, 2013 shall be subject to a fee equal to 50\n\t\t\t\tpercent of the amount of the abbreviated application fee established in\n\t\t\t\t", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}], "#text": "An\n\t\t\t\tabbreviated application which is subject to the criteria in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain\n\t\t\t\tabbreviated applications involving combination animal drugs"}, "#text": "\n                    ", "@id": "idf6c5602f895c487eab23ff78be8b7782"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions"}, "#text": "\n                  ", "@id": "idcacc9bc274074a8db26b6e5af3176db4"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any abbreviated application\n\t\t\t\twhich is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee\n\t\t\t\tif application refused for filing"}, "#text": "\n                  ", "@id": "id700c5176ac0f4e729575ac629c0538dd"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or\n\t\t\t\tportion of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was\n\t\t\t\tperformed on the application after the application was filed. The ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": "\n\t\t\t\tshall have the sole discretion to refund the fee under this subparagraph. A\n\t\t\t\tdetermination by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this subparagraph\n\t\t\t\tshall not be reviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an abbreviated application is\n\t\t\t\twithdrawn after the application was filed, the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee\n\t\t\t\tif application withdrawn"}, "#text": "\n                  ", "@id": "id52f66165be4740efa589fcf66f4f4231"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Abbreviated\n\t\t\t\tapplication fee"}, "#text": "\n                ", "@id": "idd033dcc8694346e9bfea5f744da4e5e8"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall\n\t\t\t\tpay for each such generic new animal drug product the annual fee established in\n\t\t\t\t"}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as\n\t\t\t\tthe applicant in an abbreviated application or supplemental abbreviated\n\t\t\t\tapplication for a generic new animal drug product which has been submitted for\n\t\t\t\tlisting under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idAAC47F3697D44D29AC81C4CF403D37F4", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application\n\t\t\t\tor supplemental abbreviated application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2008, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id22C71518F6FC452C98C0C0B94BC7D85A", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "iddab15399c61c4d0a8035ebba52405e39"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first\n\t\t\t\tbusiness day after the date of enactment of an appropriations Act providing for\n\t\t\t\tthe collection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id7bddf23393ad4b39b10d88411c43cad6", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of\n\t\t\t\teach year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id8830eb3b7c8748c193ac55db8ec8f2cd", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee\n\t\t\t\tdue date"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is submitted for relisting under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the generic new\n\t\t\t\tanimal drug product has been withdrawn from listing and relisted. After such\n\t\t\t\tfee is paid for that fiscal year, such fee shall be due each subsequent fiscal\n\t\t\t\tyear that the product remains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which\n\t\t\t\tthe generic new animal drug product is first submitted for listing under\n\t\t\t\t"}, "#text": "\n                  ", "@id": "id211fc9136c594c11ba4e35b782475d93"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such\n\t\t\t\tfee shall be paid only once for each generic new animal drug product for a\n\t\t\t\tfiscal year in which the fee is payable."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "id891f78304ddc40e0a2671e398b8eb9d8"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new\n\t\t\t\tanimal drug product fee"}, "#text": "\n                ", "@id": "idfd11ae881c8a4a8395dfe4a2a77d51bd"}, {"#tail": "\n            ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall\n\t\t\t\tbe assessed an annual generic new animal drug sponsor fee as established under\n\t\t\t\t"}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the\n\t\t\t\tdefinition of a generic new animal drug sponsor within a fiscal year;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id3d9927c3f8ca4d9a86d2ca1c3fea48ce", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application,\n\t\t\t\ta supplemental abbreviated application, or an investigational\n\t\t\t\tsubmission,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after\n\t\t\t\tSeptember 1, 2008, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id6ed44938f43440c286c689f69dcdbf4d", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "iddd8b31386bc8451f9cafcf8812045a00"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first\n\t\t\t\tbusiness day after the date of enactment of an appropriations Act providing for\n\t\t\t\tthe collection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idf3f3c6043fcd42a8adc1d78c4f59d909", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of\n\t\t\t\teach year."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id7e94ffff524241c29c0f544d1b328f44", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee\n\t\t\t\tdue date"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Such fee shall be due each fiscal year upon the later\n\t\t\t\tof\u2014"}, "#text": "\n                  ", "@id": "id973e315abc5b4c83ba5c0ca8a28c2dd4"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 6 approved\n\t\t\t\tabbreviated applications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "100 percent of\n\t\t\t\tthe amount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id1e219392f0c9409ba632949563e83795", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 1 and fewer than 7\n\t\t\t\tapproved abbreviated applications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "75 percent of\n\t\t\t\tthe amount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "ida54fb62d685f40789260736565e74c79", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with 1 or fewer approved abbreviated\n\t\t\t\tapplications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "50 percent of\n\t\t\t\tthe amount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idb071d68510344c6387857401259a5fca", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Amount of\n\t\t\t\tfee"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each generic new animal drug sponsor shall pay only 1 such\n\t\t\t\tfee each fiscal year, as follows:"}, "#text": "\n                  ", "@id": "id5beff016510541e2b04af8839e31f8b0"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new\n\t\t\t\tanimal drug sponsor fee"}, "#text": "\n                ", "@id": "id6557cb8279b544cbb0c55ab780769fc7"}], "#text": "\n              ", "@id": "idA929B54902514A168CBA747A059C7C37"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f", "@proposed": "true"}, {"#tail": ", the fees\n\t\t\t\trequired under ", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g", "@proposed": "true"}, {"#tail": " shall be established to generate fee revenue\n\t\t\t\tamounts as follows:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "Subject to "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fee\n\t\t\t\tamounts"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$1,832,000 for fiscal year 2014, $1,736,000 for fiscal year 2015, $1,857,000\n\t\t\t\tfor fiscal year 2016, $1,984,000 for fiscal year 2017, and $2,117,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1", "@proposed": "true"}, "#text": "The total fee revenues to be\n\t\t\t\tcollected in abbreviated application fees under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Total fee\n\t\t\t\trevenues for application fees"}, "#text": "\n                ", "@id": "idb58dd700a9284e1a9d8f8fc7404cc390"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$2,748,000 for fiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000\n\t\t\t\tfor fiscal year 2016, $2,976,000 for fiscal year 2017, and $3,175,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:2", "@proposed": "true"}, "#text": "The total fee revenues to be collected\n\t\t\t\tin generic new animal drug product fees under "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Total fee\n\t\t\t\trevenues for product fees"}, "#text": "\n                ", "@id": "id5669b7ac40eb48b79412de7b1b69dc28"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t\t$2,748,000 for fiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000\n\t\t\t\tfor fiscal year 2016, $2,976,000 for fiscal year 2017, and $3,175,000 for\n\t\t\t\tfiscal year 2018.", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:3", "@proposed": "true"}, "#text": "The total fee revenues to be collected\n\t\t\t\tin generic new animal drug sponsor fees under "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Total fee\n\t\t\t\trevenues for sponsor fees"}, "#text": "\n                ", "@id": "id051a16f1c29d483f8b09af6298f78f2a"}], "#text": "\n              ", "@id": "id1c956cf667cb4f9ca80915cb7e2b8665"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee\n\t\t\t\tsetting; adjustments"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2008, for that fiscal year,\n\t\t\t\tabbreviated application fees, generic new animal drug sponsor fees, and generic\n\t\t\t\tnew animal drug product fees, based on the revenue amounts established under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the adjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee\n\t\t\t\tsetting"}, "#text": "\n                ", "@id": "idb497e2af466147f28ffd9808017b1da2"}, {"#tail": "\n              ", "@id": "id2b530be4ba344a7c8472d1472619bf1e", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Workload\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The fee revenues shall be adjusted each fiscal year\n\t\t\t\tafter fiscal year 2014 to reflect changes in review workload. With respect to\n\t\t\t\tsuch adjustment:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change\n\t\t\t\tin the total number of abbreviated applications for generic new animal drugs,\n\t\t\t\tmanufacturing supplemental abbreviated applications for generic new animal\n\t\t\t\tdrugs, investigational generic new animal drug study submissions, and\n\t\t\t\tinvestigational generic new animal drug protocol submissions submitted to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall publish in the Federal Register the fees\n\t\t\t\tresulting from this adjustment and the supporting methodologies.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "This adjustment\n\t\t\t\tshall be determined by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idce55f0013c2843629bc3559c17c3ff6d", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}, "#text": "Under no\n\t\t\t\tcircumstances shall this workload adjustment result in fee revenues for a\n\t\t\t\tfiscal year that are less than the fee revenues for that fiscal year\n\t\t\t\testablished in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idc839937aeed44f2398c5cd749fee45df", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in addition\n\t\t\t\tto other adjustments under this subsection, further increase the fees under\n\t\t\t\tthis section, if such an adjustment is necessary, to provide for up to 3 months\n\t\t\t\tof operating reserves of carryover user fees for the process for the review of\n\t\t\t\tabbreviated applications for generic new animal drugs for the first 3 months of\n\t\t\t\tfiscal year 2019. If the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs in excess of 3 months of such operating reserves, then this\n\t\t\t\tadjustment shall not be made. If this adjustment is necessary, then the\n\t\t\t\trationale for the amount of the increase shall be contained in the annual\n\t\t\t\tnotice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Final year\n\t\t\t\tadjustment"}, "#text": "\n                ", "@id": "id79f461a2102d4ba5ae16865000a62050"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\ttotal amount of fees charged, as adjusted under this subsection, for a fiscal\n\t\t\t\tyear may not exceed the total costs for such fiscal year for the resources\n\t\t\t\tallocated for the process for the review of abbreviated applications for\n\t\t\t\tgeneric new animal drugs."}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Limit"}, "#text": "\n                ", "@id": "idab55f7fd91134a609c1f3553647115d0"}], "#text": "\n              ", "@id": "idf6f2311b96bd43de92f540e7ea172f1b"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction\n\t\t\t\tof 1 or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " finds that\n\t\t\t\tthe generic new animal drug is intended solely to provide for a minor use or\n\t\t\t\tminor species indication.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n              ", "#text": "Fee waiver or\n\t\t\t\treduction"}, "#text": "\n              ", "@id": "id474bf912dc054a5394e194a0c8ccd9d1"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be\n\t\t\t\tconsidered incomplete and shall not be accepted for filing by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tuntil all fees owed by such person have been paid. An investigational\n\t\t\t\tsubmission for a generic new animal drug that is submitted by a person subject\n\t\t\t\tto fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall be considered incomplete and shall not be\n\t\t\t\taccepted for review by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person have\n\t\t\t\tbeen paid. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may discontinue review of any abbreviated application\n\t\t\t\tfor a generic new animal drug, supplemental abbreviated application for a\n\t\t\t\tgeneric new animal drug, or investigational submission for a generic new animal\n\t\t\t\tdrug from a person if such person has not submitted for payment all fees owed\n\t\t\t\tunder this section by 30 days after the date upon which they are due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An abbreviated application for a generic new\n\t\t\t\tanimal drug submitted by a person subject to fees under "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of\n\t\t\t\tfailure to pay fees"}, "#text": "\n              ", "@id": "idd9cb7aedcb3d4858b093b99de0a4b2f7"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2008 unless appropriations for salaries and expenses of the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the ", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}, {"#tail": " for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}], "#text": "Fees\n\t\t\t\tmay not be assessed under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "#text": "\n                ", "@id": "id9edc3a6a8b1344e084165fab3c9608df"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a\n\t\t\t\tfiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " and if at a later date in such fiscal year\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such\n\t\t\t\tfees, without any modification in the rate, for abbreviated applications,\n\t\t\t\tgeneric new animal drug sponsors, and generic new animal drug products at any\n\t\t\t\ttime in such fiscal year notwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\trelating to the date fees are to be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority"}, "#text": "\n                ", "@id": "id9a9badbc35d5453db9629e9ff10fb752"}], "#text": "\n              ", "@id": "idb22582a4cdf04bd8babc79b17fd0c976"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of abbreviated applications for generic new animal drugs.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id5b018b8f434347bcbbc30f69a9b09049"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be collected and available in each fiscal year in an\n\t\t\t\tamount not to exceed the amount specified in appropriation Acts, or otherwise\n\t\t\t\tmade available for obligation for such fiscal year; and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id347363eabb5742ed8aa7e3ebe4710571", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be\n\t\t\t\tengaged in such process) over such costs, excluding costs paid from fees\n\t\t\t\tcollected under this section, for fiscal year 2008 multiplied by the adjustment\n\t\t\t\tfactor.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "shall be\n\t\t\t\tavailable to defray increases in the costs of the resources allocated for the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal drugs\n\t\t\t\t(including increases in such costs for an additional number of full-time\n\t\t\t\tequivalent positions in the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "ide9db51ba72164628b296549fe1ed056a", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014"}, "#text": "\n                  ", "@id": "id9062c4e0e546425985494248120ca399"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than\n\t\t\t\t3 percent below the level specified in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id4fb5d0dd6a4f489e9fecaeae3097a116", "#text": "\n                    "}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the\n\t\t\t\tfiscal year following the subsequent fiscal year are decreased by the amount in\n\t\t\t\texcess of 3 percent by which such costs fell below the level specified in\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id1577C26DF6A14192927D1A054851AF0E", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more than 5 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "id655045F5D8054D87866A62190C14BEE1"}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id64f07a2293324659bd822cce3a163897", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Compliance"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "#text": "\n                  ", "@id": "idd23dbbcd51834e5889d81909ce62b7ae"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior year\n\t\t\t\tappropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this section for\n\t\t\t\ta fiscal year, prior to the due date for such fees, may be accepted by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for\n\t\t\t\tearly payments"}, "#text": "\n                  ", "@id": "id19580c37f8ff4d26ad08a56edbba00a9"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and\n\t\t\t\tappropriation acts"}, "#text": "\n                ", "@id": "idc9b1a94605274f0e907affff1e4955c1"}, {"continuation-text": {"#tail": "\n                    \n                  \n                \n              ", "@continuation-text-level": "paragraph", "#text": "as\n\t\t\t\tadjusted to reflect adjustments in the total fee revenues made under this\n\t\t\t\tsection\n                         and changes in the total amounts collected by abbreviated application\n\t\t\t\tfees, generic new animal drug sponsor fees, and generic new animal drug product\n\t\t\t\tfees."}, "#tail": "\n              ", "@id": "idabfe73e158f249abb0232b9ef342c788", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                  \n                \n                    \n                      ", "#text": "Authorization\n\t\t\t\tof appropriations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "There are authorized to be appropriated for\n\t\t\t\tfees under this section\n                        \u2014"}, "#text": "\n                \n                  \n                    ", "subparagraph": [{"#tail": "\n                ", "#text": "\n                  ", "@id": "idac5784dfb4ef44e893b26b7cde670052", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,328,000 for\n\t\t\t\tfiscal year 2014", "@amount": "7328000", "@year": "2014"}, "#text": "\n                          "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "idd10cd8580e5347f9ad83be3857ca567e", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$6,944,000 for\n\t\t\t\tfiscal year 2015", "@amount": "6944000", "@year": "2015"}, "#text": "\n                          "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "idef95bb14183f45168b8ef8e5500fc69d", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,429,000 for\n\t\t\t\tfiscal year 2016", "@amount": "7429000", "@year": "2016"}, "#text": "\n                          "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "id70956af7bdf146d9bb768f9aee6dc5a5", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "; and", "#text": "$7,936,000 for\n\t\t\t\tfiscal year 2017", "@amount": "7936000", "@year": "2017"}, "#text": "\n                          "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(D)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "id4d2c2be7c3eb425d86e3526101b3071c", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$8,467,000 for\n\t\t\t\tfiscal year 2018", "@amount": "8467000", "@year": "2018"}, "#text": "\n                          "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(E)"}, "#text": "\n                    "}}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for the fiscal years 2014 through 2017, the\n\t\t\t\texcess amount shall be credited to the appropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from\n\t\t\t\tthe amount of fees that would otherwise be authorized to be collected under\n\t\t\t\tthis section pursuant to appropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:1", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe sum of the cumulative amount of fees collected under this section for the\n\t\t\t\tfiscal years 2014 through 2016 and the amount of fees estimated to be collected\n\t\t\t\tunder this section for fiscal year 2017 exceeds the cumulative amount\n\t\t\t\tappropriated under "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Offset"}, "#text": "\n                ", "@id": "id2aa2ca2dae8c4cb69c85a6a8d27d64fe"}], "#text": "\n              ", "@id": "idfb4a0834e4e44bca971de9ef32b1cb8a"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive\n\t\t\t\tpayment of a fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n              ", "@id": "id985851c562cc46b7bee05be65b7538b3"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund\n\t\t\t\tof any fee collected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit\n\t\t\t\tto the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not\n\t\t\t\tlater than 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for\n\t\t\t\tconsideration for a waiver or reduction under "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written\n\t\t\t\trequests for waivers, reductions, and refunds"}, "#text": "\n              ", "@id": "id5e73490d23ae4a99bb861fae59b1c633"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tabbreviated applications for generic new animal drugs, be reduced to offset the\n\t\t\t\tnumber of officers, employees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the "}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction"}, "#text": "\n              ", "@id": "id29448b8b6ce54925be18ca43cca6dc34"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "act", "#text": "section 742", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "#text": "In\n\t\t\t\tthis section and "}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and\n\t\t\t\t", "#text": "abbreviated application for a generic new animal drug"}, {"#tail": " mean an abbreviated application for the\n\t\t\t\tapproval of any generic new animal drug submitted under ", "#text": "abbreviated application"}], "#text": "The terms\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Such\n\t\t\t\tterm does not include a supplemental abbreviated application for a generic new\n\t\t\t\tanimal drug.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Abbreviated\n\t\t\t\tapplication for a generic new animal drug"}, "#text": "\n                ", "@id": "id9e789c630f534fc1a17705f4711f20db"}, {"#tail": "\n              ", "@id": "ida30b674c75294162b443730015f16a0c", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Adjustment\n\t\t\t\tfactor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " applicable to a\n\t\t\t\tfiscal year is the Consumer Price Index for all urban consumers (all items;\n\t\t\t\tUnited States city average) for October of the preceding fiscal year divided\n\t\t\t\tby\u2014", "#text": "adjustment factor"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2002; and", "@entity-type": "act", "#text": "subsection (f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "iddc627bb6c4f14deead951018b3911e85", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2007.", "@entity-type": "act", "#text": "subsection (g)(2)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idf3c77447412d4cf6b311d82382553bcc", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id5673217cf52d44d59d2788efbdfd28dc", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Costs of\n\t\t\t\tresources allocated for the process for the review of abbreviated applications\n\t\t\t\tfor generic new animal drugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the expenses in connection with the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal drugs\n\t\t\t\tfor\u2014", "#text": "costs of resources\n\t\t\t\tallocated for the process for the review of abbreviated applications for\n\t\t\t\tgeneric new animal drugs"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", contractors of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration"}, {"#tail": ", advisory committees consulted with respect to the review of\n\t\t\t\tspecific abbreviated applications, supplemental abbreviated applications, or\n\t\t\t\tinvestigational submissions, and costs related to such officers, employees,\n\t\t\t\tcommittees, and contractors, including costs for travel, education, and\n\t\t\t\trecruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration"}], "#text": "officers and\n\t\t\t\temployees of the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idb6172e6188464671aba1cd8e4c8cf6dd", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "management of\n\t\t\t\tinformation, and the acquisition, maintenance, and repair of computer\n\t\t\t\tresources;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id284f904c024147579ef83105e08e3c5e", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "leasing,\n\t\t\t\tmaintenance, renovation, and repair of facilities and acquisition, maintenance,\n\t\t\t\tand repair of fixtures, furniture, scientific equipment, and other necessary\n\t\t\t\tmaterials and supplies; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id86ce78a8844748a0b5cc9bb6cc761dff", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "collecting fees\n\t\t\t\tunder this section and accounting for resources allocated for the review of\n\t\t\t\tabbreviated applications, supplemental abbreviated applications, and\n\t\t\t\tinvestigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id17faa74bca3b4c2aa225ba900b4a3bc2", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect\n\t\t\t\tto a generic new animal drug product, a finished dosage form which is approved\n\t\t\t\tfor administration to an animal without substantial further manufacturing. Such\n\t\t\t\tterm includes generic new animal drug products intended for mixing in animal\n\t\t\t\tfeeds.", "#text": "final dosage form"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final dosage\n\t\t\t\tform"}, "#text": "\n                ", "@id": "id20b1eb3b785c4ec390293f0af646feab"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tnew animal drug that is the subject of an abbreviated application.", "#text": "generic new animal drug"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Generic new\n\t\t\t\tanimal drug"}, "#text": "\n                ", "@id": "id272826959c1744dcb5bed307340b9b2c"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means each specific strength or potency of a particular active\n\t\t\t\tingredient or ingredients in final dosage form marketed by a particular\n\t\t\t\tmanufacturer or distributor, which is uniquely identified by the labeler code\n\t\t\t\tand product code portions of the national drug code, and for which an\n\t\t\t\tabbreviated application for a generic new animal drug or a supplemental\n\t\t\t\tabbreviated application has been approved.", "#text": "generic new animal drug\n\t\t\t\tproduct"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Generic new\n\t\t\t\tanimal drug product"}, "#text": "\n                ", "@id": "id58927ba3757e4d39a57beee909079257"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a person who has\n\t\t\t\tsubmitted an investigational submission for a generic new animal drug that has\n\t\t\t\tnot been terminated or otherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means either an applicant named in an abbreviated application\n\t\t\t\tfor a generic new animal drug that has not been withdrawn by the applicant and\n\t\t\t\tfor which approval has not been withdrawn by the ", "#text": "generic new animal drug\n\t\t\t\tsponsor"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Generic new\n\t\t\t\tanimal drug sponsor"}, "#text": "\n                ", "@id": "id44ea039cf7554eab87ade377979465d6"}, {"#tail": "\n              ", "@id": "idfde766ad6a094af99ff2af00b289ee00", "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n                ", "#text": "Investigational\n\t\t\t\tsubmission for a generic new animal drug"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": " mean\u2014", "#text": "investigational submission"}, "term": {"#tail": " and\n\t\t\t\t", "#text": "investigational submission for a generic new animal drug"}, "#text": "The terms\n\t\t\t\t"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a generic new\n\t\t\t\tanimal drug intended to be the subject of an abbreviated application or a\n\t\t\t\tsupplemental abbreviated application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a\n\t\t\t\tclaim for an investigational exemption under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id5b080929c7b0475391d5f38fee5aaf53", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of a generic new animal drug in the event of the filing of an\n\t\t\t\tabbreviated application or supplemental abbreviated application for such\n\t\t\t\tdrug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id7b92f5fd2e404d55a274cd8bd2ab2253", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "section 735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " includes an affiliate thereof (as such term is defined\n\t\t\t\tin ", "#text": "person"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Person"}, "#text": "\n                ", "@id": "id762a596bef624fce92f8f6688bb0ef3b"}, {"#tail": "\n              ", "@id": "idcef769cd12b94d8790c5c79ae91e12ce", "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Process for\n\t\t\t\tthe review of abbreviated applications for generic new animal\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the following activities\n\t\t\t\tof the ", "#text": "process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The activities\n\t\t\t\tnecessary for the review of abbreviated applications, supplemental abbreviated\n\t\t\t\tapplications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id1d28224fcbba42f78f55cd33f84cdb7f", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The issuance of\n\t\t\t\taction letters which approve abbreviated applications or supplemental\n\t\t\t\tabbreviated applications or which set forth in detail the specific deficiencies\n\t\t\t\tin abbreviated applications, supplemental abbreviated applications, or\n\t\t\t\tinvestigational submissions and, where appropriate, the actions necessary to\n\t\t\t\tplace such applications, supplemental applications, or submissions in condition\n\t\t\t\tfor approval."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idca7ad63ac97d4c4b9af9c27fbc472598", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s review of pending abbreviated applications, supplemental\n\t\t\t\tabbreviated applications, and investigational submissions.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The inspection of\n\t\t\t\tgeneric new animal drug establishments and other facilities undertaken as part\n\t\t\t\tof the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id6b7613a72e984e13a81702dc0a34d4d6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Monitoring of\n\t\t\t\tresearch conducted in connection with the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id27e26d94202a4fb1a715b9901fb0b98e", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The development\n\t\t\t\tof regulations and policy related to the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id1f297d9205094f2e9f3f0ec77f835af8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Development of\n\t\t\t\tstandards for products subject to review."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "idbbdb71b7975c4d2cae850f74a353f26d", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Meetings between\n\t\t\t\tthe agency and the generic new animal drug sponsor."}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "idfe37190931f943e8986405691c20be94", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Review of\n\t\t\t\tadvertising and labeling prior to approval of an abbreviated application or\n\t\t\t\tsupplemental abbreviated application, but not after such application has been\n\t\t\t\tapproved."}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "@id": "id682dd24a3be843ecb77a23b85545731f", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and ", "#text": "supplemental abbreviated application for a generic new animal\n\t\t\t\tdrug"}, {"#tail": " mean a\n\t\t\t\trequest to the ", "#text": "supplemental abbreviated application"}], "#text": "The terms\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve a change in an approved abbreviated\n\t\t\t\tapplication.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}}, "enum": {"#tail": "\n                ", "#text": "(11)"}, "header": {"#tail": "\n                ", "#text": "Supplemental\n\t\t\t\tabbreviated application for generic new animal drug"}, "#text": "\n                ", "@id": "id3415d393a8314ab99d600513ca224815"}], "#text": "\n              ", "@id": "idBA43A3FF5D0B4A07A6EBEDE134DBD544"}], "#text": "\n            ", "@id": "idCE203E7223C9448BA10C1238E884DF6F"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id317629433EE749E59AA433810759A5AE"}, "#text": "\n        ", "@id": "id105B4517DF0E45CC895D417541929E33"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 742 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201322", "@value": "usc/21/379j\u201322"}, "@parsable-cite": "usc/21/379j-22", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "203."}, "header": {"#tail": "\n        ", "#text": "Reauthorization;\n\t\t\t reporting requirements"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "742."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization;\n\t\t\t\treporting requirements"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall prepare and submit to the Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate, and the Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives a report concerning the progress of\n\t\t\t\tthe Food and Drug Administration in achieving the goals identified in the\n\t\t\t\tletters described in section 201(b) of the Animal Generic Drug User Fee\n\t\t\t\tAmendments of 2013 toward expediting the generic new animal drug development\n\t\t\t\tprocess and the review of abbreviated applications for generic new animal\n\t\t\t\tdrugs, supplemental abbreviated applications for generic new animal drugs, and\n\t\t\t\tinvestigational submissions for generic new animal drugs during such fiscal\n\t\t\t\tyear.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning with fiscal year 2014, not later than 120 days\n\t\t\t\tafter the end of each fiscal year during which fees are collected under this\n\t\t\t\tpart, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance\n\t\t\t\treports"}, "#text": "\n              ", "@id": "idcc2b5fe0841b4a58a399eacfdda009d9"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report on the implementation of the\n\t\t\t\tauthority for such fees during such fiscal year and the use, by the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", of the fees collected during such fiscal year for which\n\t\t\t\tthe report is made.", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal\n\t\t\t\treport"}, "#text": "\n              ", "@id": "id835ab04b07944f3495a0b776958364cf"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports required under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet Web site of the\n\t\t\t\t", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n              ", "@id": "ide8a865f3fe1b4ddcb4bce882749273bc"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization"}, "paragraph": [{"#tail": "\n              ", "@id": "idac49410f3e04466eb5d4705b029658a1", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the goals,\n\t\t\t\tand plans for meeting the goals, for the process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs for the first 5 fiscal years after\n\t\t\t\tfiscal year 2018, and for the reauthorization of this part for such fiscal\n\t\t\t\tyears, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id4424ac037ce048e08c13f9ace54078f0", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id3c0b326cc82b4f2eb486d437381d908d", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and\n\t\t\t\tacademic experts;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id2007e9060e7f4ce0b9906b7dc174a91e", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary\n\t\t\t\tprofessionals;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "idcbae80e7d0434ac3bb6fc50b2419692b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives\n\t\t\t\tof patient and consumer advocacy groups; and"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id8a94fc1d5b374adaafd894f8aea8ad47", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated\n\t\t\t\tindustry."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "ida454eb7bb12e4255b1ef5fabeb9e6b84", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id915ae04fbce44fa68d50558bc13be3a5", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public\n\t\t\t\tinput"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the regulated industry\n\t\t\t\ton the reauthorization of this part, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register requesting public input on the reauthorization;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "iddd34e804fc044010a55d22cf279343bb", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, "#text": "hold a public\n\t\t\t\tmeeting at which the public may present its views on the reauthorization,\n\t\t\t\tincluding specific suggestions for changes to the goals referred to in\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idbdd37c4c28c545cc92470a1b8f5b60ac", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof 30 days after the public meeting to obtain written comments from the public\n\t\t\t\tsuggesting changes to this part; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id8023f630ea3b43e5b7f94f0391a2c307", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s Internet Web site.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "publish the\n\t\t\t\tcomments on the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id63c29888c82f4caca110a4dc9f89ad35", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall hold discussions\n\t\t\t\twith representatives of veterinary, patient, and consumer advocacy groups to\n\t\t\t\tcontinue discussions of their views on the reauthorization and their\n\t\t\t\tsuggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4 months during\n\t\t\t\tnegotiations with the regulated industry, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic\n\t\t\t\tconsultation"}, "#text": "\n                ", "@id": "idd320528a5f7645c38d661673a6a963e9"}, {"#tail": "\n              ", "@id": "idb6e5f2fa49e94ca7bcaf49911e87812b", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review\n\t\t\t\tof recommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After negotiations with the regulated\n\t\t\t\tindustry, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the congressional committees\n\t\t\t\tspecified in such paragraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1", "@proposed": "true"}, "#text": "present the\n\t\t\t\trecommendations developed under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id3e2b89a584794471bca05fa2ffd5c086", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such\n\t\t\t\trecommendations in the Federal Register;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "ida0a1729c8cc34b9dae0c2eaf1094eb5f", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a\n\t\t\t\tperiod of 30 days for the public to provide written comments on such\n\t\t\t\trecommendations;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id8cc0c572ab4d40babe8735eb35f0d0f8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at\n\t\t\t\twhich the public may present its views on such recommendations; and"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id94f16dea6f284626a20cfc70792d3aa4", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after\n\t\t\t\tconsideration of such public views and comments, revise such recommendations as\n\t\t\t\tnecessary."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "ida0afecd1e23a4b2492d2c63e3af311e0", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall transmit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the revised recommendations under ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", a\n\t\t\t\tsummary of the views and comments received under such paragraph, and any\n\t\t\t\tchanges made to the recommendations in response to such views and\n\t\t\t\tcomments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:4", "@proposed": "true"}], "#text": "Not later than January 15, 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations"}, "#text": "\n                ", "@id": "ide67e693bd59046f0bba725622f01a5e0"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1..5", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall make publicly\n\t\t\t\tavailable, on the Internet Web site of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t\tminutes of all negotiation meetings conducted under this subsection between the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " and the regulated industry.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Before presenting the recommendations developed\n\t\t\t\tunder "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n                  ", "@id": "id8da31d49fa5d4e03acf0fc6e923ea800"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive\n\t\t\t\tproposal made by any party to the negotiations as well as significant\n\t\t\t\tcontroversies or differences of opinion during the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tminutes described under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content"}, "#text": "\n                  ", "@id": "ide3d516771ddb4edb9694aa02f70d8dfd"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of\n\t\t\t\tnegotiation meetings"}, "#text": "\n                ", "@id": "idb6c9d4b8ddaf488fbdc61d48bc0fc4f0"}], "#text": "\n              ", "@id": "idfc6a959f0e7c4f0e9ae966273a14cbfa"}], "#text": "\n            ", "@id": "id64016AE763B143F8BB332EDA9D3D69A0"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id007B6113BEBB47D8BCF3460EDCDFD939"}, "#text": "\n        ", "@id": "id86BF1F833AFE43B28EDEE90F35A3DA96"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as in effect on the day before the date\n\t\t\t of enactment of this title, shall continue to be in effect with respect to\n\t\t\t abbreviated applications for a generic new animal drug and supplemental\n\t\t\t abbreviated applications for a generic new animal drug (as defined in such part\n\t\t\t as of such day) that on or after October 1, 2008, but before October 1, 2013,\n\t\t\t were accepted by the ", "@entity-type": "act", "#text": "part 5 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, {"#tail": " for filing with respect to\n\t\t\t assessing and collecting any fee required by such part for a fiscal year prior\n\t\t\t to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Notwithstanding the\n\t\t\t amendments made by this title, ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "204."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause"}, "#text": "\n        ", "@id": "idE3F39FD53D1C45CCAF4D42AE9FAB3054"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all abbreviated applications for a generic new\n\t\t\t animal drug and supplemental abbreviated applications for a generic new animal\n\t\t\t drug received on or after October 1, 2013, regardless of the date of enactment\n\t\t\t of this Act.", "@entity-type": "act", "#text": "part 5 of subchapter C of\n\t\t\t chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, "#text": "The amendments made by\n\t\t\t this title shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this Act, whichever is later, except that fees under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "205."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "id0093861360504679B096AF5D36435FAA"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "206."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset\n\t\t\t dates"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 741 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201321", "@value": "usc/21/379j\u201321", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-21", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization"}, "#text": "\n          ", "@id": "id7d12783b3b50456b9bcaeb4239a18160"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 742 of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j-22", "@value": "usc/21/379j-22", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-22", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting\n\t\t\t requirements"}, "#text": "\n          ", "@id": "ide4387464b55c450689665d11bd28c6a9"}, {"#tail": "\n      ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset\n\t\t\t provision"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 204 of the Animal Generic Drug User Fee Act of\n\t\t\t 2008", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, "@parsable-cite": "pl/110/316", "#text": "\n                  ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t general"}, "#text": "\n            ", "@id": "id560945a3ba304afcbfb7e9fb3fe3f851", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", by striking the\n\t\t\t item relating to ", "@entity-type": "act", "#text": "section 1", "@value": "Animal Generic Drug User Fee Act of 2008/s:1"}, {"#tail": ".", "@entity-type": "act", "#text": "section 204", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Animal Generic Drug User Fee Act of 2008", "@value": "Animal Generic Drug User Fee Act of 2008"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public\n\t\t\t Law 110\u2013316", "@value": "public-law/110/316"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n            ", "@id": "idb437a3f3cd77458aaa8b9fdd29c5c6a7", "@commented": "no"}], "#text": "\n          ", "@id": "id118d05bc7b3c4d39aef1e2668cd6cbbc", "@commented": "no"}], "#text": "\n        ", "@id": "id6738992BAF6E4409B631A215FF4D8E5C"}], "enum": {"#tail": "\n      ", "#text": "II"}, "header": {"#tail": "\n\t\t\t", "#text": "Fees relating to\n\t\t\t generic animal drugs"}, "#text": "\n      ", "@id": "id887345CBA94A46EFAF59D050D74EF0E8"}]}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S622 PCS: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}